CYTOSORBENTS CORPORATION Cash
CYTOSORBENTS CORPORATION (CTSO) had Cash of $23.80 million as of 2022-12-31, per its 10-K filed 2023-03-09.
Discontinued › Balance Sheet › Assets › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:Cash · last filed 2023-03-09
- 2022-12-31: Cash $23.80M.
- 2021-12-31: Cash $53.80M.
- 2021-09-30: Cash $61.00M.
- 2021-06-30: Cash $65.60M.
| Period end | Cash |
|---|---|
| 2022-12-31 | $23.80M 10-K · filed 2023-03-09 |
| 2021-12-31 | $53.80M 10-K · filed 2022-03-10 |
| 2021-09-30 | $61.00M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $65.60M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $68.50M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $71.40M 10-K · filed 2021-03-09 |
| 2020-09-30 | $88.00M 10-Q · filed 2020-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |